---
created: 2025-04-13
updated: 2025-04-13T10:53
id: MwQrWllfYb
specialty: ortho
specialty_id: 106
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-musculoskeletal::musculoskeletal-pathology
  - "source/ak-step1-v11:": 
  - theme/b&b::03-biochem::05-lipids::03-lipid-drugs
  - "source/ak-step1-v11:": 
  - theme/b&b::19-renal::05-other::06-rhabdomyolysis
  - "source/ak-step1-v11:": 
  - theme/firstaid::07-cardiovascular::05-pharm::10-lipid-lowering-agents::fibrates
  - "source/ak-step1-v11:": 
  - theme/firstaid::07-cardiovascular::05-pharm::10-lipid-lowering-agents::statins
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::02-pathology::33-rhabdomyolysis
  - "source/ak-step1-v11:": 
  - theme/firstaid::14-renal::04-pathology::26-rhabdomyolysis
  - "source/ak-step1-v11:": 
  - theme/nbme::21
  - "source/ak-step1-v11:": 
  - theme/nbme::22
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::09-cardiac
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::10-cardiac::09-statins
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::10-cardiac::12-fibrates
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::06-cardio::fibrates
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::06-cardio::hmg-coa-reductase-inhibitors-(statins)
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::700-799::778
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^expn::boards&beyond
  - source/ak-step1-v11::^other::^fa-updates::fa2018
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::musculoskeletal::bgadds"
type: flashcard
---

# Question
What two cholesterol modulating medications should not be combined due to a high risk of causing rhabdomyolysis?   **Statins + Fibrates**

---

# Answer
- Do not give with a cyp450 inhibitor - other drugs include daptomycin, integrase inhibitors, and drugs that can cause seizures